US$ 28.29
surmount-1 tirzepatide obesity nejm 2022 weight loss percent vs Semaglutide: Winner? π π 72-Week Data: Tirzepatide: ~20% body weight loss Semaglutide: ~14% body weight loss π‘ Tirzepatide shows greater weight & HbA1c reduction, but cost, side SURMOUNT-1 Tirzepatide Trial β 22.5%
Description
References: [1] FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes

Retrieved from MedlinePlus

Mounjaro (tirzepatide) for Type 2 Diabetes : Approved in May 2022 as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Clinical data suggests tirzepatide may lead to higher average weight loss, but semaglutide is a proven, effective treatment with a well-established safety profile

I use my compounded tirzepatide as a tool, not a crutch
